80429-41-0 Usage
Chemical structure
The compound contains a piperazine ring and an imidazole ring, which are both heterocyclic aromatic rings.
Functional groups
The presence of a hydroxypropane-1,2,3-tricarboxylate salt suggests that the compound has multiple carboxyl groups (-COOH) and a hydroxyl group (-OH).
Alkyl substituents
The compound has an ethyl group (-CH2CH3) attached to the piperazine ring and a 1-methylethyl (isopropyl) group (-CH(CH3)2) attached to the naphtho[1,2-d]imidazole core.
Aryl substituent
A 3-methoxyphenyl group (-Ar-OCH3) is attached to the piperazine ring, which may influence the compound's biological activity and pharmacokinetic properties.
Potential pharmaceutical applications
The presence of piperazine and imidazole moieties indicates that the compound may be involved in various biological activities, making it a potential candidate for pharmaceutical development.
Further research and testing
The exact uses and properties of this compound would need to be determined through additional research, experimentation, and analysis.
Salt form
The compound is presented as a salt, which can affect its solubility, stability, and bioavailability compared to its parent compound.
Check Digit Verification of cas no
The CAS Registry Mumber 80429-41-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,4,2 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 80429-41:
(7*8)+(6*0)+(5*4)+(4*2)+(3*9)+(2*4)+(1*1)=120
120 % 10 = 0
So 80429-41-0 is a valid CAS Registry Number.
80429-41-0Relevant articles and documents
Anti-hypertensives: 1-alkyl-2-arylpiperazinoethyl-1H-naphthimidazoles
Toja, Emilio,Francesco, Giuseppe Di,Barone, Domenico,Baldoli, Emiliana,Corsico. Nerina,Tarzia, Giorgio
, p. 221 - 228 (2007/10/02)
L 15848 (8b citrate) is a new anti-hypertensive agent belonging to the class of 1-alkyl-2-aminoethylnaphthimidazoles.It lowers blood pressure in spontaneously hypertensive rats (50 mg/kg, p.o.) and in conscious normotensive and renal hypertensive d